Compound details
Corynantheidine
| Compound ID | CDAMM00507 |
|---|---|
| Common name | Corynantheidine | IUPAC name | methyl 2-(3-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate |
| Molecular formula | C22H28N2O3 |
| Retention time | 11.17 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 391.198 | Theoretical mz | 391.199 |
| Error | 3.11 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.7077 |
| Inchi key | NMLUOJBSAYAYEM-LDEKCTAHNA-N |
|---|---|
| Smiles | O=C(OC)C(=COC)C1CC2C=3NC=4C=CC=CC4C3CCN2CC1CC |
| Superclass | Alkaloids and derivatives |
| Class | Corynanthean-type alkaloids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P10635 | CYP2D6 | Cytochrome P450 2D6 | T57392 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P29474 | NOS3 | Nitric-oxide synthase, endothelial | T06046 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P30531 | SLC6A1 | GABA transporter 1 | T62184 | SwissTargetPrediction |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P42785 | PRCP | Lysosomal Pro-X carboxypeptidase | T20371 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P34969 | HTR7 | Serotonin 7 (5-HT7) receptor | T79062 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| P21980 | TGM2 | Protein-glutamine gamma-glutamyltransferase | T05387 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction |
| P21918 | DRD5 | Dopamine D5 receptor | T46828 | SEA |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction and SEA |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P35368 | ADRA1B | Alpha-1b adrenergic receptor | T29500 | SwissTargetPrediction |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SwissTargetPrediction and SEA |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| Q9H2K2 | TNKS2 | Tankyrase-2 | T38087 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction and SEA |
| P23946 | CMA1 | Chymase | T05114 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| P48147 | PREP | Prolyl endopeptidase | T86161 | SwissTargetPrediction |
| P80365 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | T43721 | SwissTargetPrediction |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SwissTargetPrediction |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| P36897 | TGFBR1 | TGF-beta receptor type I | T53389 | SwissTargetPrediction |
| Q9UGN5 | PARP2 | Poly [ADP-ribose] polymerase 2 | T40812 | SwissTargetPrediction |
| P47898 | HTR5A | Serotonin 5a (5-HT5a) receptor | T15571 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction and SEA |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| P55210 | CASP7 | Caspase-7 | T72252 | SwissTargetPrediction |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SwissTargetPrediction |
| Q99835 | SMO | Smoothened homolog | T66505 | SwissTargetPrediction |
| O43174 | CYP26A1 | Cytochrome P450 26A1 | T84634 | SwissTargetPrediction |
| P02753 | RBP4 | Plasma retinol-binding protein | T55703 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SEA |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SwissTargetPrediction |
| P48067 | SLC6A9 | Glycine transporter 1 | T69685 | SwissTargetPrediction |
| P46663 | BDKRB1 | Bradykinin B1 receptor | T58589 | SwissTargetPrediction |
| P28074 | PSMB5 | Proteasome Macropain subunit MB1 | T49031 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction |
| Q9Y210 | TRPC6 | Short transient receptor potential channel 6 | T80165 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| O60760 | HPGDS | Hematopoietic prostaglandin D synthase | T19433 | SwissTargetPrediction |
| P35557 | GCK | Hexokinase type IV | T87166 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| O15151 | MDM4 | Protein Mdm4 | T36741 | SwissTargetPrediction |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| P29371 | TACR3 | Neurokinin 3 receptor | T29683 | SwissTargetPrediction |
| Q92523 | CPT1B | Carnitine O-palmitoyltransferase 1, muscle isoform (by homology) | T75888 | SwissTargetPrediction |
| Q15759 | MAPK11 | MAP kinase p38 beta | T55729 | SwissTargetPrediction |
| O43497 | CACNA1G | Voltage-gated T-type calcium channel alpha-1G subunit | T64795 | SwissTargetPrediction |
| Q9Y6F1 | PARP3 | Poly [ADP-ribose] polymerase 3 | T17228 | SwissTargetPrediction |
| Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | T92678 | SwissTargetPrediction |
| P62937 | PPIA | Cyclophilin A | T47081 | SwissTargetPrediction |
| O60911 | CTSV | Cathepsin (V and K) | T93653 | SwissTargetPrediction |
| P48544 | KCNJ5 | Kir3.1/Kir3.4 | T78692 | SwissTargetPrediction |
| P48051 | KCNJ6 | Kir3.1/Kir3.2 | T17721 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| P00488 | F13A1 | Coagulation factor XIII | T66925 | SwissTargetPrediction |
| O75884 | RBBP9 | Putative hydrolase RBBP9 | T12084 | SEA |
| Q99538 | LGMN | Legumain | T32973 | SwissTargetPrediction |
| Q10469 | MGAT2 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | T67812 | SwissTargetPrediction |
| P22735 | TGM1 | Protein-glutamine gamma-glutamyltransferase K | T63217 | SwissTargetPrediction |
| P49862 | KLK7 | Kallikrein-7 | T79155 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| P47870 | GABRB2 | GABA(A) receptor beta-2 | T80387 | SwissTargetPrediction |
| Q9HCN6 | GP6 | Platelet glycoprotein VI | T60514 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T57392 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P10635 | CYP2D6 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T06046 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P29474 | NOS3 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T62184 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30531 | SLC6A1 |
| T62184 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P30531 | SLC6A1 |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T79062 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P34969 | HTR7 |
| T79062 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34969 | HTR7 |
| T79062 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P34969 | HTR7 |
| T79062 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P34969 | HTR7 |
| T79062 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P34969 | HTR7 |
| T79062 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P34969 | HTR7 |
| T79062 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P34969 | HTR7 |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T05387 | DI0092 | Coeliac disease | [ICD-11: DA95] | P21980 | TGM2 |
| T05387 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P21980 | TGM2 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T46828 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21918 | DRD5 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T29500 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P35368 | ADRA1B |
| T29500 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35368 | ADRA1B |
| T29500 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P35368 | ADRA1B |
| T29500 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35368 | ADRA1B |
| T29500 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35368 | ADRA1B |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T38087 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9H2K2 | TNKS2 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T05114 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23946 | CMA1 |
| T05114 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P23946 | CMA1 |
| T05114 | DI0169 | Gram-positive bacterial infection | [ICD-11: 1B74-1F40] | P23946 | CMA1 |
| T05114 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P23946 | CMA1 |
| T05114 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P23946 | CMA1 |
| T05114 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P23946 | CMA1 |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T86161 | DI0092 | Coeliac disease | [ICD-11: DA95] | P48147 | PREP |
| T86161 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P48147 | PREP |
| T86161 | DI0238 | Lung cancer | [ICD-11: 2C25] | P48147 | PREP |
| T86161 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P48147 | PREP |
| T43721 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P80365 | HSD11B2 |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T53389 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P36897 | TGFBR1 |
| T53389 | DI0238 | Lung cancer | [ICD-11: 2C25] | P36897 | TGFBR1 |
| T40812 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9UGN5 | PARP2 |
| T40812 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UGN5 | PARP2 |
| T15571 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P47898 | HTR5A |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T72252 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P55210 | CASP7 |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T66505 | DI0047 | Basal cell carcinoma | [ICD-11: 2C32] | Q99835 | SMO |
| T66505 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | Q99835 | SMO |
| T66505 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99835 | SMO |
| T84634 | DI0314 | Oesophagitis | [ICD-11: DA24] | O43174 | CYP26A1 |
| T55703 | DI0212 | Inherited retinal dystrophy | [ICD-11: 9B70] | P02753 | RBP4 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T69685 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P48067 | SLC6A9 |
| T58589 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P46663 | BDKRB1 |
| T58589 | DI0365 | Retinopathy | [ICD-11: 9B71] | P46663 | BDKRB1 |
| T58589 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P46663 | BDKRB1 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T19433 | DI0148 | Flatworm infection | [ICD-11: 1F70-1F86] | O60760 | HPGDS |
| T87166 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P35557 | GCK |
| T87166 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P35557 | GCK |
| T87166 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35557 | GCK |
| T87166 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P35557 | GCK |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T36741 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O15151 | MDM4 |
| T36741 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O15151 | MDM4 |
| T36741 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O15151 | MDM4 |
| T36741 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15151 | MDM4 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T29683 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P29371 | TACR3 |
| T75888 | DI0030 | Angina pectoris | [ICD-11: BA40] | Q92523 | CPT1B |
| T75888 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q92523 | CPT1B |
| T75888 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q92523 | CPT1B |
| T55729 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q15759 | MAPK11 |
| T55729 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q15759 | MAPK11 |
| T64795 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O43497 | CACNA1G |
| T64795 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O43497 | CACNA1G |
| T64795 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | O43497 | CACNA1G |
| T64795 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O43497 | CACNA1G |
| T64795 | DI0370 | Schizophrenia | [ICD-11: 6A20] | O43497 | CACNA1G |
| T92678 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q9UDY8 | MALT1 |
| T92678 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q9UDY8 | MALT1 |
| T47081 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P62937 | PPIA |
| T93653 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | O60911 | CTSV |
| T93653 | DI0087 | Chronic pain | [ICD-11: MG30] | O60911 | CTSV |
| T78692 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P48544 | KCNJ5 |
| T78692 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | P48544 | KCNJ5 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T32973 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99538 | LGMN |
| T63217 | DI0045 | Autosomal Recessive Ichthyosis | [ICD-11: EC20] | P22735 | TGM1 |
| T80387 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P47870 | GABRB2 |
| T80387 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P47870 | GABRB2 |
| T80387 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P47870 | GABRB2 |
| T80387 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P47870 | GABRB2 |
| T60514 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q9HCN6 | GP6 |
| T60514 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | Q9HCN6 | GP6 |